1. Home
  2. RVPH vs LSF Comparison

RVPH vs LSF Comparison

Compare RVPH & LSF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RVPH
  • LSF
  • Stock Information
  • Founded
  • RVPH 2006
  • LSF 2015
  • Country
  • RVPH United States
  • LSF United States
  • Employees
  • RVPH N/A
  • LSF N/A
  • Industry
  • RVPH Biotechnology: Pharmaceutical Preparations
  • LSF Packaged Foods
  • Sector
  • RVPH Health Care
  • LSF Consumer Staples
  • Exchange
  • RVPH Nasdaq
  • LSF Nasdaq
  • Market Cap
  • RVPH 88.0M
  • LSF 71.7M
  • IPO Year
  • RVPH N/A
  • LSF 2020
  • Fundamental
  • Price
  • RVPH $1.04
  • LSF $4.71
  • Analyst Decision
  • RVPH Strong Buy
  • LSF Strong Buy
  • Analyst Count
  • RVPH 5
  • LSF 2
  • Target Price
  • RVPH $11.40
  • LSF $7.75
  • AVG Volume (30 Days)
  • RVPH 1.1M
  • LSF 94.8K
  • Earning Date
  • RVPH 05-13-2025
  • LSF 05-07-2025
  • Dividend Yield
  • RVPH N/A
  • LSF N/A
  • EPS Growth
  • RVPH N/A
  • LSF N/A
  • EPS
  • RVPH N/A
  • LSF N/A
  • Revenue
  • RVPH N/A
  • LSF $43,295,137.00
  • Revenue This Year
  • RVPH N/A
  • LSF $22.58
  • Revenue Next Year
  • RVPH N/A
  • LSF $20.06
  • P/E Ratio
  • RVPH N/A
  • LSF N/A
  • Revenue Growth
  • RVPH N/A
  • LSF 26.50
  • 52 Week Low
  • RVPH $0.60
  • LSF $1.90
  • 52 Week High
  • RVPH $4.28
  • LSF $10.90
  • Technical
  • Relative Strength Index (RSI)
  • RVPH 25.55
  • LSF 29.52
  • Support Level
  • RVPH $1.12
  • LSF $4.93
  • Resistance Level
  • RVPH $1.23
  • LSF $5.26
  • Average True Range (ATR)
  • RVPH 0.13
  • LSF 0.62
  • MACD
  • RVPH -0.03
  • LSF -0.15
  • Stochastic Oscillator
  • RVPH 0.00
  • LSF 0.72

About RVPH Reviva Pharmaceuticals Holdings Inc.

Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease, and Parkinson's disease psychosis and its other drug candidate is RP1208.

About LSF Laird Superfood Inc.

Laird Superfood Inc is engaged in the business of manufacturing and marketing differentiated plant-based and functional foods. The product portfolio includes Coffee creamers, Hydration products and beverage-enhancing supplements, Harvest snacks and various other food items, and Coffee, tea, and hot chocolate products.

Share on Social Networks: